2021 annual financial data
enGene Therapeutics Inc. 2021 Operating margin
enGene Therapeutics Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -15,870,000 USD and net income was -23,441,000 USD.
Operating cash flow was -15,984,000 USD.
Get free enGene Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,870,000 USD
- Net income
- -23,441,000 USD
- Operating cash flow
- -15,984,000 USD